Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia

Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospectiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 2007-12, Vol.46 (6), p.1191-1197.e1
Hauptverfasser: Nguyen, Louis L., MD, MBA, MPH, Brahmanandam, Soma, MD, Bandyk, Dennis F., MD, Belkin, Michael, MD, Clowes, Alexander W., MD, Moneta, Gregory L., MD, Conte, Michael S., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1197.e1
container_issue 6
container_start_page 1191
container_title Journal of vascular surgery
container_volume 46
creator Nguyen, Louis L., MD, MBA, MPH
Brahmanandam, Soma, MD
Bandyk, Dennis F., MD
Belkin, Michael, MD
Clowes, Alexander W., MD
Moneta, Gregory L., MD
Conte, Michael S., MD
description Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P < .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.
doi_str_mv 10.1016/j.jvs.2007.07.053
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2929600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521407012803</els_id><sourcerecordid>69083859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</originalsourceid><addsrcrecordid>eNp9UsGO0zAQjRCILQsfwAX5AreWsRMnDkgrrVYsIK3EAThbjj1pXZK42ElLv4jfZKJWLHBAsmTLfu_NzHvOsuccVhx4-Xq72u7TSgBUq3nJ_EG24FBXy1JB_TBbQFXwpRS8uMiepLQF4Fyq6nF2wRWXRV3LRfbzFnvTIVvj4DAyMzgWounoMHobzHrq6JSYichMSsF6M6JjBz9u2CFMhLah33XemtGHITE_sC4cSAh_jBF7Px7ZHumyOe6I_oZdD6RsumPyiYWW8QIKFnYYz_Q2RGajp9LUQuf7hvlkN6RjnmaPWtMlfHbeL7Ovt---3HxY3n16__Hm-m5pZV6MS2zLRhZGNEAWoCidKCupXImNqlsnURlT1rkDZduGI7gG8kIpFLJorbBO5ZfZ1Ul3NzU9OovDSHboXfS9iUcdjNd_vwx-o9dhr0Ut6hKABF6dBWL4PmEadU8zYEc-YpiSLmtQuZI1AfkJaGNIKWL7uwgHPcert5ri1XO8el4yJ86LP7u7Z5zzJMDLM8Ak8rCNZrA-3eMIQ_PPY7494ZC83HuMOlmPg0XnI9pRu-D_28bVP2zb-WEO7RseMW3DFCnkpLlOQoP-PP_D-RtCBVwoyPNfEVDdBQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69083859</pqid></control><display><type>article</type><title>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB Electronic Journals Library</source><creator>Nguyen, Louis L., MD, MBA, MPH ; Brahmanandam, Soma, MD ; Bandyk, Dennis F., MD ; Belkin, Michael, MD ; Clowes, Alexander W., MD ; Moneta, Gregory L., MD ; Conte, Michael S., MD</creator><creatorcontrib>Nguyen, Louis L., MD, MBA, MPH ; Brahmanandam, Soma, MD ; Bandyk, Dennis F., MD ; Belkin, Michael, MD ; Clowes, Alexander W., MD ; Moneta, Gregory L., MD ; Conte, Michael S., MD</creatorcontrib><description>Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P &lt; .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2007.07.053</identifier><identifier>PMID: 18154995</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants - administration &amp; dosage ; Anticoagulants - adverse effects ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular Agents - therapeutic use ; Dermatology ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Extremities - blood supply ; Female ; Graft Occlusion, Vascular - etiology ; Health Care Costs ; Health Resources - utilization ; Hematoma - economics ; Hematoma - epidemiology ; Hematoma - etiology ; Humans ; Incidence ; Ischemia - drug therapy ; Ischemia - economics ; Ischemia - mortality ; Ischemia - physiopathology ; Ischemia - surgery ; Limb Salvage ; Male ; Medical sciences ; Middle Aged ; North America ; Odds Ratio ; Oligonucleotides - therapeutic use ; Postoperative Hemorrhage - economics ; Postoperative Hemorrhage - epidemiology ; Postoperative Hemorrhage - etiology ; Quality of Life ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sex Factors ; Skin involvement in other diseases. Miscellaneous. General aspects ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgical Wound Infection - economics ; Surgical Wound Infection - epidemiology ; Surgical Wound Infection - etiology ; Transplantation, Autologous ; Treatment Outcome ; Vascular Patency ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels ; Vascular Surgical Procedures - adverse effects ; Vascular Surgical Procedures - economics ; Vascular Surgical Procedures - methods ; Veins - transplantation</subject><ispartof>Journal of vascular surgery, 2007-12, Vol.46 (6), p.1191-1197.e1</ispartof><rights>The Society for Vascular Surgery</rights><rights>2007 The Society for Vascular Surgery</rights><rights>2008 INIST-CNRS</rights><rights>Copyright © 2007 by The Society for Vascular Surgery. 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</citedby><cites>FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0741521407012803$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19956938$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18154995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Louis L., MD, MBA, MPH</creatorcontrib><creatorcontrib>Brahmanandam, Soma, MD</creatorcontrib><creatorcontrib>Bandyk, Dennis F., MD</creatorcontrib><creatorcontrib>Belkin, Michael, MD</creatorcontrib><creatorcontrib>Clowes, Alexander W., MD</creatorcontrib><creatorcontrib>Moneta, Gregory L., MD</creatorcontrib><creatorcontrib>Conte, Michael S., MD</creatorcontrib><title>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P &lt; .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants - administration &amp; dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular Agents - therapeutic use</subject><subject>Dermatology</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Extremities - blood supply</subject><subject>Female</subject><subject>Graft Occlusion, Vascular - etiology</subject><subject>Health Care Costs</subject><subject>Health Resources - utilization</subject><subject>Hematoma - economics</subject><subject>Hematoma - epidemiology</subject><subject>Hematoma - etiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Ischemia - drug therapy</subject><subject>Ischemia - economics</subject><subject>Ischemia - mortality</subject><subject>Ischemia - physiopathology</subject><subject>Ischemia - surgery</subject><subject>Limb Salvage</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>North America</subject><subject>Odds Ratio</subject><subject>Oligonucleotides - therapeutic use</subject><subject>Postoperative Hemorrhage - economics</subject><subject>Postoperative Hemorrhage - epidemiology</subject><subject>Postoperative Hemorrhage - etiology</subject><subject>Quality of Life</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgical Wound Infection - economics</subject><subject>Surgical Wound Infection - epidemiology</subject><subject>Surgical Wound Infection - etiology</subject><subject>Transplantation, Autologous</subject><subject>Treatment Outcome</subject><subject>Vascular Patency</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><subject>Vascular Surgical Procedures - adverse effects</subject><subject>Vascular Surgical Procedures - economics</subject><subject>Vascular Surgical Procedures - methods</subject><subject>Veins - transplantation</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsGO0zAQjRCILQsfwAX5AreWsRMnDkgrrVYsIK3EAThbjj1pXZK42ElLv4jfZKJWLHBAsmTLfu_NzHvOsuccVhx4-Xq72u7TSgBUq3nJ_EG24FBXy1JB_TBbQFXwpRS8uMiepLQF4Fyq6nF2wRWXRV3LRfbzFnvTIVvj4DAyMzgWounoMHobzHrq6JSYichMSsF6M6JjBz9u2CFMhLah33XemtGHITE_sC4cSAh_jBF7Px7ZHumyOe6I_oZdD6RsumPyiYWW8QIKFnYYz_Q2RGajp9LUQuf7hvlkN6RjnmaPWtMlfHbeL7Ovt---3HxY3n16__Hm-m5pZV6MS2zLRhZGNEAWoCidKCupXImNqlsnURlT1rkDZduGI7gG8kIpFLJorbBO5ZfZ1Ul3NzU9OovDSHboXfS9iUcdjNd_vwx-o9dhr0Ut6hKABF6dBWL4PmEadU8zYEc-YpiSLmtQuZI1AfkJaGNIKWL7uwgHPcert5ri1XO8el4yJ86LP7u7Z5zzJMDLM8Ak8rCNZrA-3eMIQ_PPY7494ZC83HuMOlmPg0XnI9pRu-D_28bVP2zb-WEO7RseMW3DFCnkpLlOQoP-PP_D-RtCBVwoyPNfEVDdBQ</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>Nguyen, Louis L., MD, MBA, MPH</creator><creator>Brahmanandam, Soma, MD</creator><creator>Bandyk, Dennis F., MD</creator><creator>Belkin, Michael, MD</creator><creator>Clowes, Alexander W., MD</creator><creator>Moneta, Gregory L., MD</creator><creator>Conte, Michael S., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071201</creationdate><title>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</title><author>Nguyen, Louis L., MD, MBA, MPH ; Brahmanandam, Soma, MD ; Bandyk, Dennis F., MD ; Belkin, Michael, MD ; Clowes, Alexander W., MD ; Moneta, Gregory L., MD ; Conte, Michael S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-ef6b54a2b0680e26d26758d6eb89fd5e8aa693d08cfb1e0db03488e254fc2cd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants - administration &amp; dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular Agents - therapeutic use</topic><topic>Dermatology</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Extremities - blood supply</topic><topic>Female</topic><topic>Graft Occlusion, Vascular - etiology</topic><topic>Health Care Costs</topic><topic>Health Resources - utilization</topic><topic>Hematoma - economics</topic><topic>Hematoma - epidemiology</topic><topic>Hematoma - etiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Ischemia - drug therapy</topic><topic>Ischemia - economics</topic><topic>Ischemia - mortality</topic><topic>Ischemia - physiopathology</topic><topic>Ischemia - surgery</topic><topic>Limb Salvage</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>North America</topic><topic>Odds Ratio</topic><topic>Oligonucleotides - therapeutic use</topic><topic>Postoperative Hemorrhage - economics</topic><topic>Postoperative Hemorrhage - epidemiology</topic><topic>Postoperative Hemorrhage - etiology</topic><topic>Quality of Life</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgical Wound Infection - economics</topic><topic>Surgical Wound Infection - epidemiology</topic><topic>Surgical Wound Infection - etiology</topic><topic>Transplantation, Autologous</topic><topic>Treatment Outcome</topic><topic>Vascular Patency</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><topic>Vascular Surgical Procedures - adverse effects</topic><topic>Vascular Surgical Procedures - economics</topic><topic>Vascular Surgical Procedures - methods</topic><topic>Veins - transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Louis L., MD, MBA, MPH</creatorcontrib><creatorcontrib>Brahmanandam, Soma, MD</creatorcontrib><creatorcontrib>Bandyk, Dennis F., MD</creatorcontrib><creatorcontrib>Belkin, Michael, MD</creatorcontrib><creatorcontrib>Clowes, Alexander W., MD</creatorcontrib><creatorcontrib>Moneta, Gregory L., MD</creatorcontrib><creatorcontrib>Conte, Michael S., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Louis L., MD, MBA, MPH</au><au>Brahmanandam, Soma, MD</au><au>Bandyk, Dennis F., MD</au><au>Belkin, Michael, MD</au><au>Clowes, Alexander W., MD</au><au>Moneta, Gregory L., MD</au><au>Conte, Michael S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>46</volume><issue>6</issue><spage>1191</spage><epage>1197.e1</epage><pages>1191-1197.e1</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Background Infrainguinal bypass (IB) surgery is an effective means of improving arterial circulation to the lower extremity for patients with critical limb ischemia (CLI). However, wound complications (WC) of the surgical incision following IB can impart significant morbidity. Methods A retrospective analysis of WC from the 1404 patients enrolled in a multicenter clinical trial of vein bypass grafting for CLI was performed. Univariate and multivariable regression models were used to determine WC predictors and associated outcomes, including graft patency, limb salvage, quality of life (QoL), resource utilization (RU), and mortality. Results A total of 543 (39%) patients developed a reported WC within 30 days of surgery, with infections (284, 52%) and hematoma/hemorrhage (121, 22%) being the most common type. Postoperative anticoagulation (odds ratio [OR], 1.554; 95% confidence interval [CI] 1.202 to 2.009; P = .0008) and female gender (OR, 1.376; 95% CI, 1.076 to 1.757; P = .0108) were independent factors associated with WC. Primary, primary-assisted, and secondary graft patency rates were not influenced by the presence of WC; though, patients with WC were at increased risk for limb loss (hazard ratio [HR], 1.511; 95% CI 1.096 to 2.079; P = .0116) and higher mortality (HR, 1.449; 95% CI 1.098 to 1.912; P = .0089). WC was not significantly associated with lower QoL at 3 months (4.67 vs 4.79, P = .1947) and 12 months (5.02 vs 5.13, P = .2806). However, the subset of patients with serious WC (SWC) demonstrated significantly lower QoL at 3 months compared with patients without WC, (4.43 vs 4.79, respectively, P = .0166), though this difference was not seen at 12 months (4.94 vs 5.13, P = .2411). Patients with WC had higher RU than patients who did not have WC. Mean index length of hospital stay (LOS) was 2.3 days longer, mean cumulative 1-year LOS was 8.1 days longer, and mean number of hospitalizations was 0.5 occurrences greater for patients with WC compared with patients without WC (all P &lt; .0001). Conclusions WC is a frequent complication of IB for CLI, associated with increased risk for major amputation, mortality, and greater RU. Further detailed investigation into the link between female gender and oral anticoagulation use with WC may help identify causes of WC and perhaps prevent or lessen their occurrence.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>18154995</pmid><doi>10.1016/j.jvs.2007.07.053</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2007-12, Vol.46 (6), p.1191-1197.e1
issn 0741-5214
1097-6809
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2929600
source MEDLINE; Elsevier ScienceDirect Journals; EZB Electronic Journals Library
subjects Administration, Oral
Aged
Aged, 80 and over
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular Agents - therapeutic use
Dermatology
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Extremities - blood supply
Female
Graft Occlusion, Vascular - etiology
Health Care Costs
Health Resources - utilization
Hematoma - economics
Hematoma - epidemiology
Hematoma - etiology
Humans
Incidence
Ischemia - drug therapy
Ischemia - economics
Ischemia - mortality
Ischemia - physiopathology
Ischemia - surgery
Limb Salvage
Male
Medical sciences
Middle Aged
North America
Odds Ratio
Oligonucleotides - therapeutic use
Postoperative Hemorrhage - economics
Postoperative Hemorrhage - epidemiology
Postoperative Hemorrhage - etiology
Quality of Life
Retrospective Studies
Risk Assessment
Risk Factors
Sex Factors
Skin involvement in other diseases. Miscellaneous. General aspects
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgical Wound Infection - economics
Surgical Wound Infection - epidemiology
Surgical Wound Infection - etiology
Transplantation, Autologous
Treatment Outcome
Vascular Patency
Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels
Vascular Surgical Procedures - adverse effects
Vascular Surgical Procedures - economics
Vascular Surgical Procedures - methods
Veins - transplantation
title Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A58%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Female%20gender%20and%20oral%20anticoagulants%20are%20associated%20with%20wound%20complications%20in%20lower%20extremity%20vein%20bypass:%20An%20analysis%20of%201404%20operations%20for%20critical%20limb%20ischemia&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Nguyen,%20Louis%20L.,%20MD,%20MBA,%20MPH&rft.date=2007-12-01&rft.volume=46&rft.issue=6&rft.spage=1191&rft.epage=1197.e1&rft.pages=1191-1197.e1&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2007.07.053&rft_dat=%3Cproquest_pubme%3E69083859%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69083859&rft_id=info:pmid/18154995&rft_els_id=S0741521407012803&rfr_iscdi=true